Plasma Levels of GDF-9 and GDF-15 in Patients With Polycystic Ovary Syndrome.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01644305
Recruitment Status :
First Posted : July 19, 2012
Last Update Posted : June 27, 2018
Ankara Education and Research Hospital
Information provided by (Responsible Party):
Zehra Berberoglu, Ankara Education and Research Hospital
1. Association of Plasma GDF-9 or GDF-15 Levels With Bone Parameters in Polycystic Ovary Syndrome. 2. Plasma GDF-15 Levels and Their Association With Hormonal and Metabolic Status in Women With Polycystic Ovary Syndrome Aged 25-35.
Actual Study Start Date :
Actual Primary Completion Date :
Actual Study Completion Date :
Resource links provided by the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
25 Years to 35 Years (Adult)
Sexes Eligible for Study:
Hospital Endocrinology Outpatient Clinic
Female patients at ages 25-35 diagnosed with polycystic ovarian syndrome and idiopathic hirsutism
acute infectious disease, a thyroid, pituitary, nutritional, inflammatory, hepatic, renal, or neoplastic disorder; history of cardiovascular disease or pulmonary embolism; a family history of coronary artery disease; smoking history; hypertension; diabetes mellitus; use of oral contraceptives, anti-androgens and drugs known to interfere with cytokine release, such as corticosteroids, immunosuppressors, or nonsteroidal antiinflammatory drugs.
any medication known to affect hormonal or metabolic parameters.